2
|
Areán PA, Pullmann MD, Griffith Fillipo IR, Wu J, Mosser BA, Chen S, Heagerty PJ, Hull TD. Randomized Trial of the Effectiveness of Videoconferencing-Based Versus Message-Based Psychotherapy on Depression. Psychiatr Serv 2024:appips20230176. [PMID: 39026468 DOI: 10.1176/appi.ps.20230176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 07/20/2024]
Abstract
OBJECTIVE The authors compared the engagement, clinical outcomes, and adverse events of text or voice message-based psychotherapy (MBP) versus videoconferencing-based psychotherapy (VCP) among adults with depression. METHODS The study used a sequential multiple-assignment randomized trial design with data drawn from phase 1 of a two-phase small business innovation research study. In total, 215 adults (ages ≥18 years) with depression received care from Talkspace, a digital mental health care company. Participants were initially randomly assigned to receive either asynchronous MBP or weekly VCP. All therapists provided evidence-based treatments such as cognitive-behavioral therapy. After 6 weeks of treatment, participants whose condition did not show a response on the Patient Health Questionnaire-9 or was rated as having not improved on the Clinical Global Impressions scale were randomly reassigned to receive either weekly VCP plus MBP or monthly VCP plus MBP. Longitudinal mixed-effects models with piecewise linear time trends applied to multiple imputed data sets were used to address missingness of data. RESULTS Participants who were initially assigned to the MBP condition engaged with their therapists over more weeks than did participants in the VCP condition (7.8 weeks for MBP vs. 4.9 weeks for VCP; p<0.001). No meaningful differences were observed between the two groups in rates of change by 6 or 12 weeks for depression, anxiety, disability, or global ratings of improvement. Neither treatment resulted in any adverse events. CONCLUSIONS MBP appears to be a viable alternative to VCP for treating adults with depression.
Collapse
Affiliation(s)
- Patricia A Areán
- Department of Psychiatry and Behavioral Medicine, University of Washington, Seattle (Areán, Pullmann, Griffith Fillipo, Mosser, Chen); Talkspace, New York City (Wu, Hull); Department of Biostatistics, School of Public Health, University of Washington, Seattle (Heagerty)
| | - Michael D Pullmann
- Department of Psychiatry and Behavioral Medicine, University of Washington, Seattle (Areán, Pullmann, Griffith Fillipo, Mosser, Chen); Talkspace, New York City (Wu, Hull); Department of Biostatistics, School of Public Health, University of Washington, Seattle (Heagerty)
| | - Isabell R Griffith Fillipo
- Department of Psychiatry and Behavioral Medicine, University of Washington, Seattle (Areán, Pullmann, Griffith Fillipo, Mosser, Chen); Talkspace, New York City (Wu, Hull); Department of Biostatistics, School of Public Health, University of Washington, Seattle (Heagerty)
| | - Jerilyn Wu
- Department of Psychiatry and Behavioral Medicine, University of Washington, Seattle (Areán, Pullmann, Griffith Fillipo, Mosser, Chen); Talkspace, New York City (Wu, Hull); Department of Biostatistics, School of Public Health, University of Washington, Seattle (Heagerty)
| | - Brittany A Mosser
- Department of Psychiatry and Behavioral Medicine, University of Washington, Seattle (Areán, Pullmann, Griffith Fillipo, Mosser, Chen); Talkspace, New York City (Wu, Hull); Department of Biostatistics, School of Public Health, University of Washington, Seattle (Heagerty)
| | - Shiyu Chen
- Department of Psychiatry and Behavioral Medicine, University of Washington, Seattle (Areán, Pullmann, Griffith Fillipo, Mosser, Chen); Talkspace, New York City (Wu, Hull); Department of Biostatistics, School of Public Health, University of Washington, Seattle (Heagerty)
| | - Patrick J Heagerty
- Department of Psychiatry and Behavioral Medicine, University of Washington, Seattle (Areán, Pullmann, Griffith Fillipo, Mosser, Chen); Talkspace, New York City (Wu, Hull); Department of Biostatistics, School of Public Health, University of Washington, Seattle (Heagerty)
| | - Thomas D Hull
- Department of Psychiatry and Behavioral Medicine, University of Washington, Seattle (Areán, Pullmann, Griffith Fillipo, Mosser, Chen); Talkspace, New York City (Wu, Hull); Department of Biostatistics, School of Public Health, University of Washington, Seattle (Heagerty)
| |
Collapse
|
3
|
Miller-Matero LR, Knowlton G, Vagnini KM, Yeh HH, Rossom RC, Penfold RB, Simon GE, Akinyemi E, Abdole L, Hooker SA, Owen-Smith AA, Ahmedani BK. The rapid shift to virtual mental health care: Examining psychotherapy disruption by rurality status. J Rural Health 2024; 40:500-508. [PMID: 38148485 DOI: 10.1111/jrh.12818] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2023] [Revised: 12/12/2023] [Accepted: 12/17/2023] [Indexed: 12/28/2023]
Abstract
BACKGROUND Given the low usage of virtual health care prior to the COVID-19 pandemic, it was unclear whether those living in rural locations would benefit from increased availability of virtual mental health care. The rapid transition to virtual services during the COVID-19 pandemic allowed for a unique opportunity to examine how the transition to virtual mental health care impacted psychotherapy disruption (i.e., 45+ days between appointments) among individuals living in rural locations compared with those living in nonrural locations. METHODS Electronic health record and insurance claims data were collected from three health care systems in the United States including rurality status and psychotherapy disruption. Psychotherapy disruption was measured before and after the COVID-19 pandemic onset. RESULTS Both the nonrural and rural cohorts had significant decreases in the rates of psychotherapy disruption from pre- to post-COVID-19 onset (32.5-16.0% and 44.7-24.8%, respectively, p < 0.001). The nonrural cohort had a greater reduction of in-person visits compared with the rural cohort (96.6-45.0 vs. 98.0-66.2%, respectively, p < 0.001). Among the rural cohort, those who were younger and those with lower education had greater reductions in psychotherapy disruption rates from pre- to post-COVID-19 onset. Several mental health disorders were associated with experiencing psychotherapy disruption. CONCLUSIONS Though the rapid transition to virtual mental health care decreased the rate of psychotherapy disruption for those living in rural locations, the reduction was less compared with nonrural locations. Other strategies are needed to improve psychotherapy disruption, especially among rural locations (i.e., telephone visits).
Collapse
Affiliation(s)
- Lisa R Miller-Matero
- Henry Ford Health, Center for Health Policy & Health Services Research, Detroit, Michigan, USA
- Henry Ford Health, Behavioral Health Services, Detroit, Michigan, USA
| | - Gregory Knowlton
- Health Partners Institute, Research and Evaluation Division, Bloomington, Minnesota, USA
| | - Kaitlyn M Vagnini
- Henry Ford Health, Center for Health Policy & Health Services Research, Detroit, Michigan, USA
- Henry Ford Health, Behavioral Health Services, Detroit, Michigan, USA
| | - Hsueh-Han Yeh
- Henry Ford Health, Center for Health Policy & Health Services Research, Detroit, Michigan, USA
| | - Rebecca C Rossom
- Health Partners Institute, Research and Evaluation Division, Bloomington, Minnesota, USA
| | - Robert B Penfold
- Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA
| | - Gregory E Simon
- Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA
| | - Esther Akinyemi
- Henry Ford Health, Behavioral Health Services, Detroit, Michigan, USA
| | - Lana Abdole
- Henry Ford Health, Behavioral Health Services, Detroit, Michigan, USA
| | - Stephanie A Hooker
- Health Partners Institute, Research and Evaluation Division, Bloomington, Minnesota, USA
| | - Ashli A Owen-Smith
- Georgia State University, School of Public Health, Kaiser Permanente Georgia, Center for Research and Evaluation, Atlanta, Georgia, USA
| | - Brian K Ahmedani
- Henry Ford Health, Center for Health Policy & Health Services Research, Detroit, Michigan, USA
- Henry Ford Health, Behavioral Health Services, Detroit, Michigan, USA
| |
Collapse
|
5
|
Ahmedani BK, Yeh HH, Penfold RB, Simon GE, Miller-Matero LR, Akinyemi E, Fallone M, Patel S, Beebani G, Hooker SA, Owen-Smith A, Knowlton G, Levin A, Eke-Usim A, Rossom RC. Psychotherapy Disruption Before and After the Transition to Virtual Mental Health Care Induced by the COVID-19 Pandemic. Psychiatr Serv 2024; 75:108-114. [PMID: 37817579 DOI: 10.1176/appi.ps.20230181] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/12/2023]
Abstract
OBJECTIVE This study aimed to examine population-level disruption in psychotherapy before and after the rapid shift to virtual mental health care induced by the onset of the COVID-19 pandemic in the United States. METHODS This retrospective study used electronic health record and insurance claims data from three U.S. health systems. The sample included 110,089 patients with mental health conditions who were members of the health systems' affiliated health plans and attended at least two psychotherapy visits from June 14, 2019, through December 15, 2020. Data were subdivided into two 9-month periods (before vs. after COVID-19 onset, defined in this study as March 14, 2020). Psychotherapy visits were measured via health records and categorized as in person or virtual. Disruption was defined as a gap of >45 days between visits. RESULTS Visits in the preonset period were almost exclusively in person (97%), whereas over half of visits in the postonset period were virtual (52%). Approximately 35% of psychotherapy visits were followed by a disruption in the preonset period, compared with 18% in the postonset period. Disruption continued to be less common (adjusted OR=0.45) during the postonset period after adjustment for visit, mental health, and sociodemographic factors. The magnitude of the difference in disruption between periods was homogeneous across sociodemographic characteristics but heterogeneous across psychiatric diagnoses. CONCLUSIONS This study found fewer population-level disruptions in psychotherapy receipt after rapid transition to virtual mental health care following COVID-19 onset. These data support the continued availability of virtual psychotherapy.
Collapse
Affiliation(s)
- Brian K Ahmedani
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Hsueh-Han Yeh
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Robert B Penfold
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Gregory E Simon
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Lisa R Miller-Matero
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Esther Akinyemi
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Marisa Fallone
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Shivali Patel
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Ganj Beebani
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Stephanie A Hooker
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Ashli Owen-Smith
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Gregory Knowlton
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Albert Levin
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Angela Eke-Usim
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| | - Rebecca C Rossom
- Center for Health Policy and Health Services Research (Ahmedani, Yeh, Miller-Matero), Behavioral Health Services (Ahmedani, Miller-Matero, Akinyemi, Fallone, Patel, Beebani), and Public Health Sciences (Levin), Henry Ford Health, Detroit; Kaiser Permanente Washington Health Research Institute, Seattle (Penfold, Simon); HealthPartners Institute, Minneapolis (Hooker, Knowlton, Rossom); Center for Research and Evaluation, Kaiser Permanente Georgia, and Department of Health Policy and Behavioral Sciences, Georgia State University, Atlanta (Owen-Smith); Authority Health, Detroit (Eke-Usim)
| |
Collapse
|
6
|
Gui J, Han Z, Ding R, Yang X, Yang J, Luo H, Huang D, Wang L, Jiang L. Depression associated with dietary intake of flavonoids: An analysis of data from the National Health and Nutrition Examination Survey, 2007-2010. J Psychosom Res 2023; 173:111468. [PMID: 37611347 DOI: 10.1016/j.jpsychores.2023.111468] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2023] [Revised: 08/15/2023] [Accepted: 08/16/2023] [Indexed: 08/25/2023]
Abstract
BACKGROUND Flavonoids may have a protective effect against depression. The purpose of this study was to examine whether flavonoid intake was associated with depression. METHODS This is an observational cross-sectional study. We evaluated a sample of 8183 adults from the National Health and Nutrition Examination Survey (NHANES), 2007-2010. The participants had an average age of 46.7 years, and 48.4% of them were male. Flavonoid intake was obtained through dietary recall interviews, and it included six subclasses: isoflavones, anthocyanidins, flavan-3-ols, flavanones, flavones, and flavonols. Depression was identified using the Patient Health Questionnaire (PHQ-9). Logistic regression was utilized to evaluate the association between flavonoid intake and depression. Restricted cubic splines (RCS) were utilized to investigate nonlinear associations. Differences between subgroups were explored. Mediation analysis was used to explore confounding/mediating factors. These models were adjusted for age, sex, race/ethnicity, poverty status, education, smoking status, alcohol consumption, BMI, energy intake, physical activity, and chronic diseases. RESULTS There were 765 individuals with depression (PHQ-9 score ≥ 10) in the sample. After adjusting for covariates, flavanones, flavones, and total flavonoid intake were associated with a lower likelihood of depression (OR (95% CI): 0.73(0.64,0.84); 0.36(0.21,0.63); 0.86(0.74,0.99), respectively). A significant inverse correlation was observed between flavonoid consumption and the somatic symptom score of the PHQ-9. We observed a stronger association between flavonoids and depression in non-Hispanic white groups. The relationship between the total flavonoid intake and depression was explained to some extent by sleep duration (13.8%). CONCLUSIONS Flavonoid intake was associated with lower odds of depression.
Collapse
Affiliation(s)
- Jianxiong Gui
- Department of Neurology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
| | - Ziyao Han
- Department of Neurology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
| | - Ran Ding
- Department of Neurology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
| | - Xiaoyue Yang
- Department of Neurology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
| | - Jiaxin Yang
- Department of Neurology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
| | - Hanyu Luo
- Department of Neurology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
| | - Dishu Huang
- Department of Neurology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
| | - Lingman Wang
- Department of Neurology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
| | - Li Jiang
- Department of Neurology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China.
| |
Collapse
|